$67.27
+0.770 (+1.16%)
At Close: Jun 23, 2026
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results
11:40am, Wednesday, 26'th Mar 2025
MMSI unveils 12-month efficacy data for WRAPSODY CIE, highlighting its advanced technology in vascular access maintenance and potential to improve patient outcomes.
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
09:25am, Tuesday, 25'th Mar 2025
SOUTH JORDAN, Utah, March 25, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that the six-month results from the randomi
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership
09:25am, Tuesday, 18'th Mar 2025
SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred L
Merit Medical: A Success Story That Keeps Getting Better
12:34pm, Sunday, 16'th Mar 2025
Merit Medical continues to outperform, with the share price supported by on-target financial results, incremental M&A, and positive clinical data. The company's Wrapsody stent graft showed almost best
MMSI Announces Commencement of Patient Enrollment in PREEMIE Study
10:15am, Friday, 14'th Mar 2025
Merit Medical aims to improve care for vulnerable premature infants by evaluating the safety and efficacy of the Bloom Micro Occluder System for treating PDA in the specified patient pool.
First Patient Enrolled in Merit Medical's PREEMIE Study
09:25am, Monday, 10'th Mar 2025
Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants Multicenter, prospective study
Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript
10:39pm, Tuesday, 25'th Feb 2025
Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript
Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics
07:35pm, Tuesday, 25'th Feb 2025
While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics
Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates
06:56pm, Tuesday, 25'th Feb 2025
Merit Medical (MMSI) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.81 per share a year ago.
Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance
04:05pm, Tuesday, 25'th Feb 2025
Fourth Quarter Highlights† Reported revenue of $355.2 million, up 9.4% Constant currency revenue* and constant currency revenue, organic* up 10.1% and up 6.1%, respectively GAAP operating margin of
Gear Up for Merit Medical (MMSI) Q4 Earnings: Wall Street Estimates for Key Metrics
10:21am, Monday, 24'th Feb 2025
Evaluate the expected performance of Merit Medical (MMSI) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key m
Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now
01:45pm, Friday, 21'st Feb 2025
Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
10:51am, Friday, 07'th Feb 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Looking for a Growth Stock? 3 Reasons Why Merit Medical (MMSI) is a Solid Choice
01:45pm, Wednesday, 05'th Feb 2025
Merit Medical (MMSI) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
10:46am, Monday, 03'rd Feb 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Sign In
Buy MMSI